Consulting Services
For Investors
Products
Case Studies
Insights
- Conference Previews
- Conference Social Media Reports
BioPharma and Tech News

Contact Us

Search

pertuzumab

Oncology News

Oncology Video Recap—January 5, 2026

This Oncology video recap covering news from the last thre weeks brings…

Onco_background

Oncology Today: ADCs, PD-L1 & FDA Wins (Oct 6–13, 2025)

This week’s oncology highlights include breakthrough therapies such as ADCs…

Onco_background

Oncology Weekly News - September 29th 2025

Oncology Update: Vorasidenib Approval, Plixorafenib Efficacy, OPDIVO…

Categories

Obesity News
Endocrinology News
Our Insights
Immunology News
Case studies
Hematology News
BioPharma and Tech News
Oncology News
BioPharma Strategy, CI and AI Guides
Lucid Diligence Brief
Conference Social Media Reports
Venture Capital Trends
AI in Healthcare and Digital Health
Conference Previews
Cell and Gene Therapy News
Rare Disease News
Neuroscience News
Women's Health News
Public Health News
Respiratory News
Cardiovascular News
Vaccine news

Recent Posts

Lucid Diligence Brief: Angitia Biopharmaceuticals $130 million Series D
Vaccines Video Recap—February 6, 2026
Respiratory Video Recap—February 6, 2026
Public Health Today—February 6, 2026
Vaccines Today—February 6, 2026

Tags

Alto Neuroscience antimicrobiotics pipeline bifidobacteria Bird Flu Vaccine bone mineral density Brigham and Women’s Hospital Cardiovascular Disease Colorectal Cancer coronary physiology cutaneous venous malformations Darzalex Digital Inhaler Ebola Virus Disease Eli Lilly Erythropoietic protoporphyria Evommune FDA updates fibrosis treatment Gene therapy for diabetes HCPs HepatitisB Hodgkin Lymphoma Hunter Syndrome Immunai immunooncology India Pharma LGBTIQ Health Longevity industry Love in Mind Lucid Quest Lymphoma mrna vaccines MyoStep nivolumab pandemic preparedness Paracetamol pediatric hemophilia pulsed field ablation Regenexx Rybelsus synthetic data T1D Tafasitamab TAVR ZEVASKYN

Archives

Archives

LucidQuest Ventures

Accelerate Your Success

LATEST NEWS

Lucid Diligence Brief: Angitia Biopharmaceuticals $130 million Series D
Vaccines Video Recap—February 6, 2026
Respiratory Video Recap—February 6, 2026
Public Health Today—February 6, 2026
Vaccines Today—February 6, 2026

TAGS

Alto Neuroscience antimicrobiotics pipeline bifidobacteria Bird Flu Vaccine bone mineral density Brigham and Women’s Hospital Cardiovascular Disease Colorectal Cancer coronary physiology cutaneous venous malformations Darzalex Digital Inhaler Ebola Virus Disease Eli Lilly Erythropoietic protoporphyria Evommune FDA updates fibrosis treatment Gene therapy for diabetes HCPs HepatitisB Hodgkin Lymphoma Hunter Syndrome Immunai immunooncology India Pharma LGBTIQ Health Longevity industry Love in Mind Lucid Quest Lymphoma mrna vaccines MyoStep nivolumab pandemic preparedness Paracetamol pediatric hemophilia pulsed field ablation Regenexx Rybelsus synthetic data T1D Tafasitamab TAVR ZEVASKYN

Consulting Services
For Investors
Products
Case Studies
Insights
- Conference Previews
- Conference Social Media Reports
BioPharma and Tech News

© 2026 LucidQuest Ventures. All rights reserved

We use cookies from third party services to offer you a better experience. Read about how we use cookies and how you can control them by clicking "Privacy Preferences".

Privacy Preference Center

Privacy Preferences

When you visit any website, it may store or retrieve information on your browser in the form of cookies. Since we respect your right to privacy, you can choose not to permit data collection from certain types of services. However, not allowing these services may impact your experience ans we are able to offer you.

Privacy Policy

Required

You read and agreed to our Privacy Policy

Tracking

We use third-party cookies that help us analyze and understand how you use this website. These cookies do not store any personal information.

Privacy Policy